Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bayleyegn2016 - interactions of CycE/Cdk2, Cdc25A, and P27 Kip1 in a core cancer subnetwork

ABSTRACT: Mathematical description of the interactions of CycE/Cdk2, Cdc25A, and P27Kip1 in a core cancer subnetwork. Model is encoded by Matthieu Maire/partially by Krishna Kumar Tiwari and submitted to BioModels by Krishna Kumar Tiwari.

SUBMITTER: Krishna Kumar Tiwari

PROVIDER: MODEL2003180002 | BioModels | 2020-03-18

REPOSITORIES: BioModels

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	MODEL2003180002?filename=Bayleyegn2016.cps	Other
	MODEL2003180002?filename=Bayleyegn2016.sedml	Other
	MODEL2003180002?filename=Bayleyegn2016.xml	Xml

Items per page:

1 - 3 of 3

Similar Datasets

Gidvani2012 - DNA replication initiation model in S. Cevevisiae

Project description:A quantitative model of the initiation of DNA replication in Saccharomyces cerevisiae predicts the effects of system perturbations. Model is encoded by Matthew Maire and submitted in BioModels by Krishna Kumar Tiwari.

2020-05-06 | MODEL2003180001 | BioModels

Chiorino2002 - G1/S transition model

Project description:mathematical approach to model the protein interactions regulating the transition from the G1 phase to the phase of DNA synthesis. Model is encoded by matthieu Maire and submitted to BioModels by krishna kumar tiwari.

2020-03-19 | MODEL2003180003 | BioModels

Novak1998 - Mathematical model of fission yeast cell cycle

Project description:Mathematical model of the fission yeast cell cycle with checkpoint controls at the G1/S, G2/M and metaphase/anaphase transitions. Model encoded by Matthieu Maire and submitted to BioModels by Krishna kumar Tiwari.

2020-03-19 | MODEL2003190004 | BioModels

Vibert2017 - Tcell proliferation model

Project description:model allows us to infer proliferation rates and cell cycle phase durations from complex experimental 5-ethynyl-2'-deoxyuridine (EdU) data, revealing T cell proliferation heterogeneity and specific signatures. Model is encoded by Matthew Maire and submitted in BioModels by Krishna Kumar Tiwari.

2020-03-17 | MODEL2003170002 | BioModels

Starbuck1990 - EGF binding and trafficking dynamics in Fibroblast

Project description:mathematical model, with accompanying quantitative experimental data, for binding and trafficking properties of the epidermal growth factor (EGF) receptor on B82 fibroblasts, and propose a theoretical dependence of cell proliferation rate on these properties. Model encoded by Matthieu Maire adn submitted to BioModels by Krishna Kumar Tiwari.

2020-03-19 | MODEL2003190005 | BioModels

Segun2018 - model of breast cancer determing Chemotherapy and Keto diet response

Project description:optimal control theory is applied to find out the optimal drug adjustment as an input control of the system therapies to minimize the number of cancerous cells by considering different controlled combinations of administering the chemotherapy agent and ketogenic diet using the popular Pontryagin’s Maximum Principle. Numerical simulations were presented to validate our theoretical results. Model is encoded by Jinghoa Men and submitted to BioModels by Krishna Tiwari.

2025-01-15 | MODEL2003050001 | BioModels

Core Collection resequencing of safflower

Project description:Core collection for safflower was created by our group previously Kumar et al 2016, the current study undertakes whole genome resequencing of the same along with 7 additional lines of agronomic importance.

| PRJEB81559 | ENA

CDK2 knockdown in prostate cancer cell lines

Project description:CDK2 is a cyclin-dependent kinase involved in regulating cell cycle progression. In prostate cancer, CDK2 has been shown to be associated with poor survival. We sought to identify key genes and molecular pathways regulated by CDK2 in prostate cancer. We therefore knocked down CDK2 using siRNA in PC3 and ResA cell lines, and performed RNA-seq.

2025-07-16 | GSE282801 | GEO

Liu2017 - chemotherapy targeted model of tumor immune system

Project description:Its a mathematical model reflecting chemotherapy response in tumor immune interaction system. Model encoded by Sarubini Kananathan and annotated+submitted to Biomodels by Krishna Tiwari

2024-09-02 | BIOMD0000000930 | BioModels

Inactivation of CDK2 is synthetic lethal to MYCN-overexpressing cancer cells

Project description:Two genes have a synthetic lethal relationship when silencing or inhibition of one gene is only lethal in the context of a mutation or activation of the second gene. This situation offers an attractive therapeutic strategy, as inhibition of such a gene will only trigger cell death in tumor cells with an activated second oncogene but spare normal cells without activation of the second oncogene. Here we present evidence that CDK2 is synthetic lethal to neuroblastoma cells with MYCN amplification and overexpression. Neuroblastomas are childhood tumors with an often lethal outcome. Twenty percent of the tumors have MYCN amplification and these tumors are ultimately refractory to any therapy. Targeted silencing of CDK2 by three RNA interference techniques induced apoptosis in MYCN-amplified neuroblastoma cell lines, but not in MYCN single copy cells. Silencing of MYCN abrogated this apoptotic response in MYCN-amplified cells. Inversely, silencing of CDK2 in MYCN single copy cells did not trigger apoptosis, unless a MYCN transgene was activated. The MYCN induced apoptosis after CDK2 silencing was accompanied by nuclear stabilization of P53 and mRNA profiling showed up-regulation of P53 target genes. Silencing of P53 rescued the cells from MYCN-driven apoptosis. The synthetic lethality of CDK2 silencing in MYCN activated neuroblastoma cells can also be triggered by inhibition of CDK2 with a small molecule drug. Treatment of neuroblastoma cells with Roscovitine, a CDK inhibitor, at clinically achievable concentrations induced MYCN-dependent apoptosis. The synthetic lethal relation between CDK2 and MYCN indicates CDK2 inhibitors as potential MYCN-selective cancer therapeutics. CDK2 shRNA in a tet repressor system was stably transfected in the IMR32 cell line. Time course analysis was performed in triplicate after induction of CDK2 shRNA at 5 time points.

2014-05-19 | E-GEOD-16480 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data